新橋生物 NBP 深 滬
等待開盤 05-23 09:30:00 美东时间
1.76
-0.020
-1.12%
華盛通- 最 高1.82
- 今 開1.78
- 成交量 71.37万股
- 最 低 1.76
- 昨 收 1.78
- 總市值 2.04亿
- 52周最高 6.79
- 市盈率 靜 --
- 換手率 0.62%
- 52周最低 1.20
- 委 比 -50.54%
- 總股本 1.16亿
- 歷史最高 85.40
- 量 比 0.80
- 振 幅 3.37%
- 歷史最低 0.595
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
NovaBridge Biosciences announced that its management team will participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference on May 19, 2026. The event will feature a fireside chat at 3:30 PM ET, with a webcast available on NovaBridge's website for 90 days. NovaBridge, a global biotech company focused on accelerating innovative medicines, highlighted its pipeline, including givastomig, a Claudin 18.2 X 4-1BB bispecific antibody for...
05-12 11:00
Alpha Buying: Insider Conviction in High-Risk Biotech
Insider buying matters in every industry, but it carries a special weight in bi...
05-08 00:04
NovaBridge Biosciences Appoints Mark Hagler As President And Chief Commercial Officer
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design and business development discussionsStrong industry reputation and commercial track record in
04-22 19:11
I-Mab Biopharma GAAP EPS of -$0.48
I-Mab Biopharma press release (NBP): FY GAAP EPS of -$0.48. As of December 31, 2025, the Company had cash, cash equivalents, and short-term investments of $210.8 million. The Company’s current cash po...
04-08 05:26
NovaBridge Biosciences director Conor Chia-hung Yang files initial beneficial ownership statement
NovaBridge Biosciences director Conor Chia-hung Yang files initial beneficial ownership statement NovaBridge Biosciences director Conor Chia-hung Yang reported employee share options covering 148,623 ADSs, per an initial beneficial ownership filing dated March 18, 2026. Disclaimer: This news brief w
04-01 18:12
NovaBridge Biosciences CFO Lei Ming Kyler files initial beneficial ownership statement
NovaBridge Biosciences CFO Lei Ming Kyler files initial beneficial ownership statement NovaBridge Biosciences filed an initial statement of beneficial ownership naming Lei Ming Kyler as Chief Financial Officer. Lei Ming Kyler reported a 2025 Employee Share Option covering 996,775 ordinary shares. Th
03-19 09:40
NovaBridge Biosciences Director Fu Wei Files Initial Beneficial Ownership Statement
NovaBridge Biosciences Director Fu Wei Files Initial Beneficial Ownership Statement NovaBridge Biosciences reported an initial statement of beneficial ownership filed by Fu Wei, a director. The filing listed indirect holdings of 11,784,164 ordinary shares through CBC Investment l-Mab. It also report
03-19 09:38
NovaBridge Biosciences director Emmett Cunningham files initial beneficial ownership statement
NovaBridge Biosciences director Emmett Cunningham files initial beneficial ownership statement NovaBridge Biosciences reported that Emmett Cunningham filed an initial statement of beneficial ownership as a director. The filing disclosed a 2025 employee share option covering 120,000 shares with an ex
03-19 09:36
NovaBridge Biosciences Director Liu Xin Files Initial Beneficial Ownership Statement
NovaBridge Biosciences Director Liu Xin Files Initial Beneficial Ownership Statement NovaBridge Biosciences filed an initial statement of beneficial ownership on March 18, 2026. The filing lists Xin Liu as a director. The form states that no securities are beneficially owned by Xin Liu. Disclaimer:
03-19 09:35
